White Papers / Tech Papers
Effective Technology Transfers for Mammalian-Derived Biologics
As a leader of technology transfer activities in the industry, Lonza understands the challenges associated with this critical step.
Released by
Lonza
11.06.23
More White Papers / Tech Papers by Lonza
More Content From Lonza
-
Discover how this scalable and robust technology can facilitate the development and manufacturing of your bioconjugate drug.
-
Learn more about the scale up of antibody drug conjugates payloads by viewing this webinar.
-
Lonza's Michiya Hayakawa provides an overview of the current market and presents strategies for manufacturing highly potent active drugs.